Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P36980 (
CFHR2
)
30
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The complement factor H-related (FHR) proteins are hypothesized to fine-tune the regulatory role of complement factor H (FH) in the alternative pathway of the complement system. Moreover, FHR-1,
FHR-2
, and
FHR-5
have been proposed to be dimers, which further complicates accurate analysis. As FHRs are highly similar among themselves and toward FH, obtaining specific reagents for quantification of serum levels and functional analysis is challenging. In this study, we generated antibodies and developed ELISAs to measure FHR-1,
FHR-2
, and
FHR-5
in serum. We used both recombinant and serum-derived proteins to show that four dimers occur in human circulation: homodimers of FHR-1,
FHR-2
, and
FHR-5
, as well as FHR-1/
FHR-2
heterodimers. Heterodimers containing
FHR-5
were not found. In individuals with homozygous
CFHR1
deletions or compound heterozygous
CFHR2
missense/nonsense mutations identified in this study, the respective FHR-1 and
FHR-2
homo- and heterodimers were absent. Using FRET, we found that recombinant FHR dimers exchange monomers rapidly. This was confirmed
ex vivo
, using FHR-1- and
FHR-2
-deficient sera. Of all FHR dimers,
FHR-5
/5 homodimers demonstrated strong binding affinity toward heparin. Specific ELISAs demonstrated that serum levels of FHR-1/1, FHR-1/2,
FHR-2
/2, and
FHR-5
/5 dimers were low compared to FH, which circulates at a 10- to 200-fold molar excess. In summary, FHR-1,
FHR-2
, and
FHR-5
homodimerize, with FHR-1 and
FHR-2
forming heterodimers as well, and equilibrate quickly in plasma.
...
PMID:Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma. 2909 12
Complement is activated as part of the innate immune defense against invading pathogens. Also, it helps to remove apoptotic debris and immune complexes from the circulation. Impaired complement function due to aberrant plasma levels of complement proteins may be indicative for complement-mediated diseases or can be involved in susceptibility for infections. To determine whether plasma levels are abnormal, reference intervals (RIs) are used from adult healthy donors. Since many complement-mediated diseases have an onset during childhood, it is important to know whether these RIs can be extrapolated to children. RIs of Factor H (FH), the crucial fluid-phase regulator, and the FH-related proteins (FHRs), its homologous counterparts, are unknown in healthy children. While FH is measured to diagnose and monitor therapy of patients with atypical hemolytic uremic syndrome, recent studies also implicated increased plasma levels of FHRs in disease. Here, we investigated the levels of FH and FHRs in healthy children using recently developed specific ELISAs. We found that levels of FH,
FHR-2
, and FHR-3 were equal to those found in healthy adults. Levels of FHR-4A and
FHR-5
were lower in children than in adults. However, only the
FHR-5
levels associated with age. The RIs of these FH family proteins now serve to support the interpretation of plasma levels in prospective and retrospective studies that can be used for routine diagnostic and monitoring purposes including pediatric patient samples.
...
PMID:Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children. 3011 38